PDCD1 and lip and oral cavity carcinoma: Moreover, our previous studies showed that PD-1 blockade can prevent the malignant progression of OPLs, in a mouse model for oral carcinogenesis, supporting the preventive potential of immune checkpoint inhibition to contain oral cancer development [14].